Oncology
News
Original COVID-19 vaccines fall short against Omicron subvariants for the immunocompromised
Findings from a CDC-supported study suggest that updated, bivalent boosters targeting recently circulating Omicron subvariants may benefit adults...
Conference Coverage
High-quality index colonoscopies pay off down the road for low-risk patients
Later risk for advanced adenomas, serrated polyps, or colorectal cancer was lower for patients with an initial high-quality colonoscopy.
News
‘Financial toxicity’: Harsh side effect of cancer care
High costs of cancer treatment can induce more anxiety and distress than the treatment itself.
Conference Coverage
Pancreatic cancer screening appears safe, effective for high-risk patients
The study explored a targeted strategy for screening since pancreatic cancer screening is not recommended for the general population.
Latest News
Reminder that COVID-19 and cancer can be a deadly combo
“This analysis provides additional empirical evidence on the magnitude of risk to patients with cancer whose immune systems are often weakened...
Conference Coverage
One-third of pancreatic cancer diagnoses missed on scans
The time window for curative surgery is often short, and missing the diagnosis can result in worse clinical outcomes.
News
Sigmoidoscopy screening cuts CRC mortality, incidence
A pooled analysis of four large trials showed a 21% reduction in CRC incidence after sigmoidoscopy screening, compared with usual care.
News
Colonoscopy lowers CRC risk and death, but not by much: NordICC
In an intention-to-screen analysis, 10-year results from the NordICC trial show that colonoscopy reduces the risk of colorectal cancer by only 18...
News
Will AI affect the burden of patient surveillance after polyp removal?
AI-assisted colonoscopy may increase the proportion of patients requiring intensive postpolypectomy colonoscopy surveillance by roughly 35% in the...
News
Cost paramount when choosing metastatic breast cancer treatment
“Our analysis provides quantifiable evidence to help providers choose lower priced, but equally effective sequences of drugs.”